TL;DR: Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg — hence the nickname “EDR peptide.” It comes out of Vladimir Khavinson’s short-peptide bioregulator program in St. Petersburg, and it’s marketed as a biorregulador cerebral (brain bioregulator) aimed at neuroprotection, oxidative-stress resistance, and cognitive maintenance. It shows up in two very different formats: RUO lyophilized vials for laboratory reconstitution, and the consumer “Cytogen” oral capsule that’s especially popular in Spanish and Latin American wellness circles. The catch: nearly all published data is cell-culture and rodent work from a single research lineage, with no independent Western human trials. Here’s the honest picture.
The EDR peptide in one paragraph
Pinealon is one of Khavinson’s “ultrashort” peptides — chains of just 2 to 7 amino acids proposed to act as endogenous signaling molecules. At three residues (glutamic acid, aspartic acid, arginine), it’s tiny, water-soluble, and carries the kind of charge profile that its developers argue lets it cross cell membranes and even reach DNA. The theory of peptide bioregulation holds that these short peptides bind promoter regions and nudge gene expression in the tissue they’re “tuned” to — for Pinealon, that target tissue is the brain and, historically, the pineal gland it’s named after.
The bioregulator concept: why “short” matters
The whole Khavinson framework rests on the idea that regulatory information doesn’t need a big molecule. Where a classic protein hormone might be dozens or hundreds of residues, a bioregulator like Pinealon is proposed to work at the transcriptional level with just three. In the group’s model, the EDR sequence interacts with specific double-stranded DNA motifs in the promoter regions of genes tied to neuronal survival and antioxidant defense — names that show up in their papers include SOD2, GPX1, CASP3, TP53, and IGF1.
If you want the full family tree — Epitalon, Thymalin, Cortagen, Vesugen and the rest — the Khavinson bioregulators guide lays out how these short peptides are grouped by target organ.
What the neuroprotection research actually shows
The most-cited experimental work is cell-culture. In cerebellar granule cells, neutrophils, and PC12 cells put under oxidative stress, Pinealon produced a dose-dependent restriction of reactive oxygen species (ROS) accumulation and cut necrotic cell death. Researchers also reported a shifted, delayed ERK1/2 activation signal — a pathway involved in cell survival and cycle regulation.
In animals, a rodent study reported that Pinealon given under prenatal hyperhomocysteinemia conditions left offspring with better cognitive-task performance and cerebellar neurons that were more resistant to oxidative stress. Aged-animal learning studies from the same program point the same direction.
Volume and independence of the published record by study type. Human column reflects consumer-format clinical reports, not independent RCTs.
The mechanistic throughline is consistent: reduce oxidative damage, support antioxidant enzyme expression, keep neurons viable under stress. That’s a coherent story. It’s also almost entirely preclinical and largely single-lineage.
The Cytogen capsule vs. the RUO vial
This is where Pinealon gets culturally interesting. Two formats coexist:
- Cytogen oral capsules — the consumer product, each containing roughly 10 mg of synthesized peptide complex (marketed as the “A-7 / AC-5” brain formula). Typical label usage is 1–2 capsules once or twice daily, about 30 minutes before food, in ~1-month cycles repeated every few months. This is the format you’ll see branded as Cytogen Pinealon, péptido cerebral, or biorregulador cerebral across Spanish and LatAm longevity shops — an oral, self-directed wellness product.
- RUO lyophilized vials — the Pinealon 20mg research vial, sold strictly for laboratory use, reconstituted with bacteriostatic water. If you’re modeling reconstitution volumes or per-unit amounts, the peptide calculator handles the arithmetic, and the reconstitution guide walks through the method.
The oral format is notable because being “ultrashort” is exactly what makes oral delivery plausible for a peptide — most peptides are digested before absorption, but a three-residue chain has a better shot at surviving intact. That’s the marketing pitch; independent bioavailability data in humans remains thin.
Common stacks people ask about
Two combinations dominate the forums:
- The “sleep stack” (Pinealon + Epitalon). Epitalon is the pineal bioregulator most associated with melatonin rhythm and telomere research, so pairing it with a brain-targeted peptide is the classic Khavinson circadian combo. Start with what is Epitalon and the Epitalon 10mg page if that’s the angle.
- The “brain stack” (Pinealon + Semax). Semax is a separate Russian nootropic peptide (BPC-unrelated, ACTH-derived) often stacked with Pinealon for a “neuroprotection plus acute focus” rationale. Semax isn’t a Khavinson bioregulator, so this is a cross-family combination rather than an in-house pairing.
Neither stack has controlled human outcome data behind it — they’re community protocols built on mechanistic plausibility, not trials.
The honest bottom line
Pinealon is a genuinely interesting molecule: a real synthetic tripeptide with a real, internally consistent body of preclinical antioxidant and neuroprotective research, plus a decades-old theoretical framework. What it doesn’t have is independent, Western, randomized human evidence that it improves memory or cognition. Most published work traces to one research program, and independent replication is limited. Treat the enthusiasm — and the biorregulador cerebral marketing — as hypothesis, not proof.
Frequently Asked Questions
What does “EDR peptide” mean?
EDR is the single-letter amino-acid code for Pinealon’s sequence: E (glutamic acid), D (aspartic acid), R (arginine) — i.e., Glu-Asp-Arg. The names “Pinealon” and “EDR peptide” refer to the same tripeptide.
Is Pinealon the same as Epitalon?
No. Both are Khavinson pineal-associated bioregulators, but Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly) studied mainly for circadian and telomere endpoints, while Pinealon is the EDR tripeptide framed around neuroprotection. They’re often discussed together and sometimes stacked.
Why does Pinealon come as an oral capsule when most peptides are injected?
Because it’s ultrashort — just three amino acids. Very short peptides have a better chance of surviving digestion intact than large ones, which is the rationale behind the Cytogen oral-capsule format popular in Spanish and LatAm markets. Human bioavailability data remains limited.
Is there human evidence that Pinealon improves cognition?
There are consumer-format clinical reports from its developers, but no independent Western randomized controlled trials showing memory or cognition benefit. The strongest data is cell-culture and rodent work on oxidative-stress resistance.
What’s a common Pinealon stack?
The two most-asked pairings are Pinealon + Epitalon (a circadian/“sleep” combo) and Pinealon + Semax (a “brain/focus” combo). Both are community protocols based on mechanism, not on controlled trial outcomes.
References
- Khavinson VKh, et al. “EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease.” Molecules. 2021;26(1):159.
- Arutjunyan A, Kozina L, Stvolinskiy S, Bulygina Y, Mashkina A, Khavinson V. “Pinealon protects the rat offspring from prenatal hyperhomocysteinemia.” International Journal of Clinical and Experimental Medicine. 2012;5(2):179–185. (PMC3342713)
- Khavinson VKh, et al. “Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes.” Bulletin of Experimental Biology and Medicine. 2011. (Cell-culture ROS and cell-viability study.)
- Kolchina N, Khavinson V, et al. “Peptide Regulation of Gene Expression: A Systematic Review.” Molecules. 2021;26(22):7053.
- Khavinson VKh, Malinin VV. Gerontological Aspects of Genome Peptide Regulation. Karger, Basel. (Overview of the short-peptide bioregulator framework.)
This article is for research and educational reference only. Pinealon is not an approved medicine, this is not medical advice, and it is not for human consumption.